Previous Close | 12.50 |
Open | 12.50 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 290.00 |
Expire Date | 2025-01-17 |
Day's Range | 12.50 - 12.50 |
Contract Range | N/A |
Volume | |
Open Interest | 7 |
Charles River (CRL) announces the development of non-clinical VCG with Sanofi to reduce the use of animals in research.
WILMINGTON, Mass., June 11, 2024--Charles River announces an integrated program, funded by a $1.3 million grant, to develop an in vitro alternative to inhalation toxicology studies
WILMINGTON, Mass., June 06, 2024--Charles River announces the opening of a new CRADL® facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub.